Enhancing Epilepsy Treatment Planning

Having a family member, especially a young child, suffer from epilepsy is cause for a great deal of stress. At MEGIN, we have designed our equipment to be as unobtrusive as possible, allowing a quick and accurate assessment to be made in as little time as possible.

50 million

people worldwide have epilepsy

2.4 million

people are diagnosed with epilepsy globally each year

$15.5 billion

in direct and indirect costs in the US each year due to epilepsy

Enhancing Epilepsy Treatment Planning

Having a family member, especially a young child, suffer from epilepsy is cause for a great deal of stress. At MEGIN, we have designed our equipment to be as unobtrusive as possible, allowing a quick and accurate assessment to be made in as little time as possible.

50 million

people worldwide have epilepsy

2.4 million

people are diagnosed with epilepsy globally each year

$15.5 billion

in direct and indirect costs in the US each year due to epilepsy

The benefits of MEG in epilepsy treatment planning

MEG is a valuable tool for characterizing and localizing epileptic activity, as well as localizing brain function. The scans are non-invasive, silent, and well tolerated by patients of all ages, including young children.

A powerful tool for epilepsy clinicians

Use of MEG leads to improved surgical outcomes. It provides a direct measure of electrophysiology, and the signal is not distorted by skull and scalp. Clinicians appreciate the accuracy of MEG scans, which offer temporal and spatial accuracy – to the millisecond and millimeter.

Global Offices

MEGIN OY
Siltasaarenkatu 18-20
00530 Helsinki
Finland
Tel: +358 9 756 2400
View on map

MEGIN US LLC
11772 W Sample Road
Coral Springs, FL 33065
United States of America
Tel: +1 954 341 5374
View on map

MEGIN Medical LTD
78-79 Pall Mall
London, England
SW1Y 5ES
Tel: +44 0203 7098138
View on map

info@megin.fi

Enquiry Form